Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of sequential versus concurrent cisplatin-based chemoradiotherapy in inoperable non-small cell lung cancer
ISRCTN73271276Phase 3Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin in non-small cell lung cancer (NSCLC), sponsored by Netherlands Cancer Institute. Primary endpoints: Disease-free survival, Local control and 1 more. Started May 2003; status: completed.
02
Drugs
cisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ISRCTN73271276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73271276.